ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 116 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $59,000 | -9.2% | 22,000 | 0.0% | 0.05% | -10.9% |
| Q1 2019 | $65,000 | +85.7% | 22,000 | 0.0% | 0.06% | +111.5% |
| Q4 2018 | $35,000 | -56.8% | 22,000 | 0.0% | 0.03% | -38.1% |
| Q3 2018 | $81,000 | +30.6% | 22,000 | 0.0% | 0.04% | +23.5% |
| Q2 2018 | $62,000 | -57.2% | 22,000 | -43.6% | 0.03% | -55.3% |
| Q1 2018 | $145,000 | +29.5% | 39,000 | 0.0% | 0.08% | +46.2% |
| Q4 2017 | $112,000 | -36.0% | 39,000 | 0.0% | 0.05% | -35.0% |
| Q3 2017 | $175,000 | -2.2% | 39,000 | 0.0% | 0.08% | -4.8% |
| Q2 2017 | $179,000 | +6.5% | 39,000 | -2.5% | 0.08% | +10.5% |
| Q1 2017 | $168,000 | +1.8% | 40,000 | 0.0% | 0.08% | -5.0% |
| Q4 2016 | $165,000 | -76.0% | 40,000 | -52.9% | 0.08% | -77.3% |
| Q3 2016 | $687,000 | -16.8% | 84,850 | -19.8% | 0.35% | -14.9% |
| Q2 2016 | $826,000 | -4.2% | 105,850 | -5.2% | 0.42% | -6.5% |
| Q1 2016 | $862,000 | -82.7% | 111,650 | -75.8% | 0.44% | -81.7% |
| Q4 2015 | $4,969,000 | +41.0% | 460,550 | -9.7% | 2.43% | +32.9% |
| Q3 2015 | $3,525,000 | -28.1% | 510,125 | -7.8% | 1.83% | -16.6% |
| Q2 2015 | $4,900,000 | -1.0% | 553,000 | +10.2% | 2.19% | -4.5% |
| Q1 2015 | $4,949,000 | -21.9% | 501,950 | -3.0% | 2.29% | -24.3% |
| Q4 2014 | $6,339,000 | +17.1% | 517,450 | -4.6% | 3.03% | +11.9% |
| Q3 2014 | $5,412,000 | -1.6% | 542,325 | -25.3% | 2.71% | +4.0% |
| Q2 2014 | $5,498,000 | +48.9% | 726,225 | -35.3% | 2.60% | +37.1% |
| Q1 2014 | $3,692,000 | +13.7% | 1,122,325 | +14.8% | 1.90% | +11.0% |
| Q4 2013 | $3,246,000 | +1491.2% | 978,025 | +1345.7% | 1.71% | +1426.8% |
| Q3 2013 | $204,000 | -47.0% | 67,650 | +43.9% | 0.11% | -49.1% |
| Q2 2013 | $385,000 | – | 47,005 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |